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We show that noxiustoxin (NTX), like charybdotoxin (CTX) described by others, affects CaZt-activated 
K+ channels of skeletal muscle (K+(Ca2+) channels). Chemical characterization of CTX shows that it is 
similar to NTX. Although the amino-terminal amino acid of CTX is not readily available, the molecule 
was partially sequenced after CNBr cleavage. A decapeptide corresponding to the C-terminal region of 
NTX shows 60% homology to that of CTX, maintaining the cysteine residues at the same positions. While 
CTX blocks the K+(Ca2+) channels with a & of 1-3 nM, for NTX it is approx. 450 nM. Both peptides 
can interact simultaneously with the same channel. NTX and CTX promise to be good tools for channel 
isolation. 
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1. INTRODUCTION 
In recent years, the understanding of the struc- 
ture and function of membrane-bound receptor 
proteins, including ion channels, has been greatly 
increased, due to the discovery of specific natural 
peptide inhibitors used as probes at molecular and 
cellular levels [l-6]. Although many different 
types of K+ channels have been extensively studied 
electrophysiologically, few biochemical data are 
available [7,8], primarily due to the lack of specific 
biochemical igands for isolating channels in pure 
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form. From a variety of substances described as 
blockers of K+ channels (Cs’, tetraethylam- 
monium, 4-aminopyridine, etc., see review [9]), 
none have proven to be useful tools for channel 
isolation, because of the high concentration need- 
ed (millimolar range) and lack of specificity. 
Recently, CTX, a protein isolated from the 
venom of the scorpion Leiurus quinquestriatus 
quinquestriatus was shown to block K+(Ca2+) 
channels from rat skeletal muscle [lo]. In single- 
channel recordings, CTX induced long-lived non- 
conducting states characteristic of a high-affinity 
channel blockade. The effect was reversible and 
was shown to be attributable to a basic peptide 
with a molecular mass in the range 7-10 kDa [ll]. 
NTX, a peptide with 39 amino acid residues, was 
isolated from the venom of the scorpion Cen- 
truroides noxius [12] and was shown to block the 
voltage-dependent K+ channel from squid axon 
[ 13,141, and changed K+ permeability in brain 
synaptosomes [ 151. Since neither the primary 
structure of CTX nor the effect of NTX on 
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K+(Ca’+) channels was known, we have decided to 
verify the structure of CTX and compare the effect 
of both peptides in skeletal muscle preparation by 
means of single-channel recording techniques, 
which is the subject of this communication. 
2. MATERIALS AND METHODS 
2.1. Materials 
Only analytical grade reagents were used 
throughout the purification and characterization 
procedures; sources have been previously indicated 
1161. 
Venom from the scorpion C. noxius was ob- 
tained by electrical stimulation of anesthetized 
animals [16], while venom from L. q. quin- 
questriatus was purchased from Sigma (St. Louis, 
MO). 
2.2. Purification of toxins 
NTX was purified as in [17]. CTX was purified 
by a three-step procedure. The soluble venom 
(100 mg) from L. q. quinquestriatus was gel 
filtered on a Sephadex G-50 column (1.8 x 
200 cm), equilibrated in 20 mM ammonium 
acetate buffer, pH 4.7. The blocking activity of 
CTX-containing fractions was followed by 
monitoring their effect on channels incorporated 
into bilayers, as described below. Fraction III 
eluting from the Sephadex column displayed CTX 
activity and was further separated in a CM- 
cellulose column (0.9 x 30 cm) equilibrated in 
20 mM ammonium acetate buffer, pH 4.7, and 
eluted with a salt gradient (from 0 to 0.5 M NaCl 
in the same buffer). Fraction 13 contained CTX 
activity and was finally purified by high- 
performance liquid chromatography (HPLC) us- 
ing a reverse-phase column similarly to the work of 
Smith et al. [ll]. Homogeneity of samples was 
confirmed by polyacrylamide gel electrophoresis in 
two different systems [18,191. The first system con- 
tained acetate-urea buffers. The second contained 
SDS and the sample was reduced by boiling in the 
presence of 5% ,&-mercaptoethanol, and applied to 
the gel for determination of the molecular mass. A 
small aliquot of CTX (5Opg) was isotopically 
labeled with “‘1 by the lactoperoxidase method of 
Morrison and Bayse [20] and also run in parallel to 
verify that the protein-staining band in the gel cor- 
responded to the radiolabeled CTX. 
2.3. Chemical characterization of CTX 
A sample of CTX was hydrolyzed in 6 N HCI 
[16] and the composition was determined in a 
Beckman 6300 amino acid analyzer. Another ali- 
quot of CTX (5Opg) was reduced and 
pyridylethylated as in [12]. Part of this material 
was directly loaded in the spinning cup of a 
Beckman 890M microsequencer for automatic Ed- 
man degradation [21]; another aliquot of the 
reduced and alkylated toxin was cleaved with 
CNBr [ 161, and separated by HPLC for further se- 
quence analysis. 
2.4. Preparation of transverse tubule-enriched 
membranes, and planar bilayer methods 
Membranes derived from the transverse tubule 
of skeletal muscle were prepared by a slight 
modification of the procedure of Meissner [22]. 
Membrane fractions from the 10120 and 20/25% 
sucrose interfaces routinely show high PN 
200-l lo-binding activity and were therefore used 
for incorporation of transverse tubule ion channels 
into the planar bilayers of a Mueller-Rudin type of 
chamber. Single-channel currents were measured 
via a List EPC-7 patch clamp electrometer (List 
Electronic, Darmstadt) and filtered through an 
&pole Bessel low-pass filter. Analog signals from 
the patch clamp were digitized and stored on 
10 Mbyte hard disks for later analysis with soft- 
ware run on an IBM-AT computer. 
3. RESULTS AND DISCUSSION 
Gel electrophoresis analysis of CTX purified by 
our procedure shows that it migrates as a single 
component of apparent molecular mass 4.8 kDa 
(see fig. 1). The electrophoretic mobility of CTX is 
between that of y-toxin (7 kDa) and NTX 
(4.2 kDa), which were used as molecular mass 
markers. Furthermore, 1251-CTX migrates as a 
single component and corresponds to the protein 
band stained with Coomassie blue in the gel. The 
final recovery of CTX obtained by this procedure 
is of the order of 0.5070, assuming a molar extinc- 
tion coefficient of 17000 M-’ . cm-‘, as suggested 
[ 111. The amino acid composition of CTX 
reported by Smith et al. [l l] is close to the values 
we have found, except for their assumption of a 
molecular mass of 9.2 kDa, twice of what we have 
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Fig. 1. SDS gel electrophoresis of native and iodinated CTX. The gel was sliced into 0.5cm portions and ‘251-CTX was 
counted in a gamma-counter. The peak of radioactivity co-migrates with the protein band on the gel (see slab-gel strip 
horizontally placed). A mixture of molecular mass markers was applied in the same gel, in parallel, in order to determine 
the apparent molecular mass of CTX. A linear plot (log molecular mass vs Rf of markers) showed the molecular mass 
of CTX to be 4.8 kDa. The following markers (in kDa) were used: phosphorylase b (92.5), bovine serum albumin (62.5), 
ovalbumin (45), carbonic anhydrase (31), soybean trypsin inhibitor (21.5), lysozyme (14) (see lane 1). Lane 2 contains 
4pg y-toxin from T. serrulutus (7 kDa); and lane 3 is CTX (2pg). 
found. For example, they have reported 6 Arg, 2 
His, 2 Tyr and 2 Phe; we have found exactly half 
of these values. However, we do agree on the 
values of Be (0) and Met (1). Values for the com- 
position of the amino acid Met are usually 
underestimated because of partial oxidation. It is 
worth mentioning that cysteines were measured as 
cysteic acid, after oxidation with performic acid 
[l 11, and we do obtain the same number of 
residues (6) per molecule of CTX. Except for the 
discrepancy in molecular mass we conclude that we 
are studying the same CTX molecule, because both 
are basic peptides, are extracted from the same 
source of scorpion venom, have very similar affini- 
ty (&) for the same type of channels measured via 
the same method and display the same kinetic 
behavior towards the K+(Ca’+) channels. 
For the first time it has been shown that NTX af- 
fects the K+(Ca2+) channels of skeletal muscle (see 
fig.2), suggesting the possible existence of a related 
family of toxic peptides in scorpion venom, which 
affect these channels, and that an important 
stretch of the CTX primary structure is 
homologous with NTX. We were unable to obtain 
direct sequencing data with the intact CTX 
molecule, probably because the N-terminal amino 
acid is blocked. For this reason we have treated 
CTX with CNBr. Two peptides were generated, 
one corresponding to the blocked N-terminal pep- 
tide and another with the following sequence: Met- 
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Fig.2. Effect of toxins on single-channel currents of 
Ca’+-activated K+ channels from skeletal muscle T- 
tubules. (A) Single K+(Ca’+) channels were recorded in 
250 mM KC1 (internal side), 50 mM KCl, 200 mM NaCl 
(external side). Upper trace, control activity at 0 mV, 
500 Hz filter, 2 kHz sampling. Open probability (PO) 
was 0.85. Second trace shows the effect of 800 nM NTX 
added trans. PO was reduced to 0.44. (B) Blockade 
produced by CTX and NTX. Upper trace, control (PO = 
0.80). Second trace was recorded with 20 nM CTX 
added to the external side of the channel (tram). PO from 
entire file (10 min recording time) was 0.12. Third trace 
shows the effect produced by 20 nM CTX plus 2,uM 
NTX trans. Lowermost recording is an expansion of the 
right-hand burst of activity shown in the third trace. 
Recordings were taken at 0 mV, 500 Hz filter and 2 kHz 
sampling. (C) Dose-response curves for CTX and NTX 
blockade of K+(Ca’+) channels. (Left) Reciprocal of the 
mean active time [lo] vs CTX concentration. The slope 
gives a second-order rate constant of block, Ken = 
l/[CTX]r,,, = 0.053 x lo9 M-‘.s-‘. The apparent Kd = 
K&K,, = 1.8 nM. (Right) Plot of P,, (fraction open 
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CHARYBDOTOXIN (nb.4) NOXIUSTOXIN (nt.4) 
Asn-Lys-Lys-Cys-Arg-Cys-Tyr-Ser-Ser. As shown 
in table 1 this sequence corresponds to the 
decapeptide at the C-terminal amino acid sequence 
of NTX with 60% identity and with perfect align- 
ment of the cysteinyl residues. The blocking effects 
of both peptides on K+(Ca’+) channels are shown 
in fig.2. NTX reduces open probability by driving 
the channel into a brief blocked state. The CTX 
trace shows the characteristic long-term blockade 
of K+(Ca’+) channels produced by 20 nM CTX. 
Both toxins are only effective when added to the 
external face of the channel. Blocked states in- 
Table 1 
Comparison of the C-terminal amino acid sequence of noxiustoxin with that of a CNBr-cleaved 
peptide from charybdotoxin 
Scornion toxin Amino acid sequence 
C. noxius 1 30 35 
noxiustoxin Thr-Ile-Ile- . . . . . Met-Asn-Gly-Lys-Cys-Lys-Cys-Tyr-Asn-Asn 
L. 4. quinquestriatus 
charybdotoxin blocked (?) . . . . .Met-Asn-Lys-Lys-Cys-ArgCys-Tyr- Ser - Ser 
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duced by CTX were typically lo-15 s in duration 
at room temperature. 2/M NTX added in the 
presence of CTX had an additional inhibitory ef- 
fect. In the presence of both toxins channels 
displayed blocked states of long and short duration 
characteristic of those produced by each toxin add- 
ed separately (trace CTX + NTX). When bursts of 
activity in the presence of both toxins were exam- 
ined on an expanded time scale, the open and clos- 
ed events appeared kinetically similar to those seen 
in the presence of NTX alone (cf. final and NTX 
traces). Thus, apparently, both CTX and NTX can 
interact simultaneously with the same ion channel. 
At this point, however, it is not clear whether the 
toxin-binding sites are the same for CTX and 
NTX. The difference in mean duration of toxin- 
induced blocked states (7 = 10 s for CTX and 7 = 
50 ms for NTX) is most easily explained by the dif- 
ferent apparent affinities of the two toxins for in- 
hibitory sites on the channel. The & values 
obtained in a series of experiments conducted with 
different concentrations of both toxins indicated 
that CTX has a Kd of l-3 nM, while for NTX it 
is 450 nM (see fig.2C). Similar differences in af- 
finity were found when comparing the & of NTX 
for the delayed rectifier of squid axon (of the order 
of 290 nM [13]) with the EDso (approx. 2 nM) in 
the release of y-aminobutyric acid from brain 
synaptosomes [15]. Although the specificity of 
NTX seems to be rather broad concerning the type 
of K+ channels affected, it seems to be related ex- 
clusively to K+ channels [13-l 51. It does not 
modify Na+ or Ca2+ currents [ 13- 151. Our results 
support the idea that CTX and NTX are can- 
didates for use as tools for K+ channel isolation. 
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